Zai Lab updates risks: employee medical fraud probes in China, Optune patent setbacks

Zai Lab Ltd

Several current/former employees in ZEJULA sales team under criminal investigation by Chinese authorities for alleged medical insurance fraud; individuals detained or under compulsory measures.
Two Chinese patents covering Optune were successfully invalidated; decision on appeal. Optune-related patents expected to expire within two years.
Company warns of material adverse effects from data privacy non-compliance, anti-corruption investigations (including FCPA), and licensing disputes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.